Your session is about to expire
← Back to Search
Supportive Care for Breast Cancer
N/A
Waitlist Available
Led By Meagan Whisenant
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 3 months
Awards & highlights
Study Summary
This trial is testing an e-health support program to help newly diagnosed breast cancer patients with symptoms like pain, fatigue, depression, and anxiety. The goal is to improve overall health.
Eligible Conditions
- Breast Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline up to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Impact of electronic (e)-health support program on patient reported outcomes
Side effects data
From 2023 Phase 1 & 2 trial • 28 Patients • NCT0434560183%
Anemia
67%
Lymphocyte count decreased
58%
Platelet count decreased
58%
Alanine aminotransferase increased
50%
Hypokalemia
42%
Hyponatremia
42%
Fever
33%
Blood bicarbonate decreased
33%
Hypoalbuminemia
33%
Creatinine increased
33%
Diarrhea
33%
Hypocalcemia
33%
Lung infection
33%
Aspartate aminotransferase increased
25%
Hyperkalemia
25%
Atrial fibrillation
25%
Hypophosphatemia
25%
Hematuria
25%
Hypotension
25%
Hypertriglyceridemia
25%
Hypermagnesemia
25%
Proteinuria
17%
Hematoma
17%
Vomiting
17%
Glucosuria
17%
Dizziness
17%
Hyperphosphatemia
17%
Hypernatremia
17%
Anxiety
17%
Hypercalcemia
17%
Vascular disorders - Other, specify:DVT
17%
Pneumothorax
17%
Anorexia
17%
Hypoxia
17%
Urinary tract infection
8%
Hyperuricemia
8%
Sepsis
8%
Pleural effusion
8%
Multi-organ failure
8%
White blood cell decreased
8%
Sinus tachycardia
8%
Blood bilirubin increased
8%
Cardiac troponin I increased
8%
Acute kidney injury
8%
Blood lactate dehydrogenase increased
8%
Urinary retention
8%
Rash maculo-papular
8%
Asystole
8%
Acidosis
8%
Constipation
8%
Thromboembolic event
8%
Syncope
8%
Hypertension
8%
Hypoglycemia
8%
Ileus
8%
Respiratory failure
8%
Lipase increased
8%
Cytomegalovirus infection reactivation
8%
Palpitations
8%
Bacteremia
8%
Dyspepsia
8%
Folliculitis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Control Group
Safety Run In
Mesenchymal Stromal Cells (MSCs)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (Pack Health Program)Experimental Treatment2 Interventions
Patients participate in the Pack Health Program which includes up to 60 scheduled touch points via phone, text, email and a mobile application and weekly interaction with a health coach over 3 months. They also have access to standard of care support services at MD Anderson including a telephone triage line 5 days a week between 8 a.m. and 5 p.m.
Group II: Group II (standard of care support services)Active Control2 Interventions
Patients receive standard of care support services with a telephone triage line available 5 days a week between 8 a.m. and 5 p.m.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Supportive Care
2013
Completed Phase 2
~1710
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,980 Previous Clinical Trials
1,789,390 Total Patients Enrolled
148 Trials studying Breast Cancer
63,286 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,701 Previous Clinical Trials
40,929,159 Total Patients Enrolled
942 Trials studying Breast Cancer
1,543,966 Patients Enrolled for Breast Cancer
Meagan WhisenantPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
287 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings to join this research endeavor?
"As per clinicaltrials.gov, this research is no longer actively recruiting patients. The trial was initially posted on May 19th 2017; however it hasn't been updated since November 1st 2022. Despite this fact, there are still 2291 other studies currently seeking out participants for enrolment."
Answered by AI
Share this study with friends
Copy Link
Messenger